US FDA clears NeuroPro Spinal Jaxx fusion device


The US Food and Drug Administration has cleared NeuroPro’s Spinal Jaxx expandable intervertebral spacer.

Spinal Jaxx is an expandable lumbar interbody fusion device for spinal surgeries. The design of the spacer and proprietary tool set are intended to allow surgeons to insert the spacer between the vertebrae of patients in its collapsed form in order to minimise the incision and patient trauma. The spacer is designed to then be expanded to customise the height of the implant to the specific anatomical needs of the patient. Finally, implant design and toolset should allow the surgeon to insert as much bone graft into the spacer and disc space as desired after the device has been expanded.

According to a press release, the design allows surgeons to insert the device into a collapsed disc space and expand it in situ to a larger size as needed, providing a snug fit.

The company release states that Spinal Jaxx technology also offers:

1) Instruments that enable the surgeon to pack additional bone graft through portals in the implant after it has been implanted and expanded

2) A locking mechanism that prevents any collapse of the device once it is expanded.

3) Titanium endplates that contact the vertebral bodies.

4) Greater expansion capability than most competing products means that a smaller implant can be inserted and still adequately expand to fill the interbody space.